203 related articles for article (PubMed ID: 23630584)
1. Mutant p53 attenuates the anti-tumorigenic activity of fibroblasts-secreted interferon beta.
Madar S; Harel E; Goldstein I; Stein Y; Kogan-Sakin I; Kamer I; Solomon H; Dekel E; Tal P; Goldfinger N; Friedlander G; Rotter V
PLoS One; 2013; 8(4):e61353. PubMed ID: 23630584
[TBL] [Abstract][Full Text] [Related]
2. Regulation of XAF1 expression in human colon cancer cell by interferon beta: activation by the transcription regulator STAT1.
Sun Y; Qiao L; Xia HH; Lin MC; Zou B; Yuan Y; Zhu S; Gu Q; Cheung TK; Kung HF; Yuen MF; Chan AO; Wong BC
Cancer Lett; 2008 Feb; 260(1-2):62-71. PubMed ID: 18035482
[TBL] [Abstract][Full Text] [Related]
3. ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.
Forys JT; Kuzmicki CE; Saporita AJ; Winkeler CL; Maggi LB; Weber JD
Cell Rep; 2014 Apr; 7(2):514-526. PubMed ID: 24726362
[TBL] [Abstract][Full Text] [Related]
4. SOCS1 links cytokine signaling to p53 and senescence.
Calabrese V; Mallette FA; Deschênes-Simard X; Ramanathan S; Gagnon J; Moores A; Ilangumaran S; Ferbeyre G
Mol Cell; 2009 Dec; 36(5):754-67. PubMed ID: 20005840
[TBL] [Abstract][Full Text] [Related]
5. [SOCS1 knockdown sensitize anti-tumor activity of IFN-alpha2a-NGR].
Huang QC; Lei XY; Liu Y; Sui WJ; Li S; Zhang YQ; Yan Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 May; 26(5):412-5. PubMed ID: 20423643
[TBL] [Abstract][Full Text] [Related]
6. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts.
Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R
J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216
[TBL] [Abstract][Full Text] [Related]
7. Tumour-promoting role of SOCS1 in colorectal cancer cells.
Tobelaim WS; Beaurivage C; Champagne A; Pomerleau V; Simoneau A; Chababi W; Yeganeh M; Thibault P; Klinck R; Carrier JC; Ferbeyre G; Ilangumaran S; Saucier C
Sci Rep; 2015 Sep; 5():14301. PubMed ID: 26391193
[TBL] [Abstract][Full Text] [Related]
8. Interferon-β induces cellular senescence in cutaneous human papilloma virus-transformed human keratinocytes by affecting p53 transactivating activity.
Chiantore MV; Vannucchi S; Accardi R; Tommasino M; Percario ZA; Vaccari G; Affabris E; Fiorucci G; Romeo G
PLoS One; 2012; 7(5):e36909. PubMed ID: 22615843
[TBL] [Abstract][Full Text] [Related]
9. A20 regulates atherogenic interferon (IFN)-γ signaling in vascular cells by modulating basal IFNβ levels.
Moll HP; Lee A; Minussi DC; da Silva CG; Csizmadia E; Bhasin M; Ferran C
J Biol Chem; 2014 Nov; 289(45):30912-24. PubMed ID: 25217635
[TBL] [Abstract][Full Text] [Related]
10. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.
Ji L; Xu J; Liu J; Amjad A; Zhang K; Liu Q; Zhou L; Xiao J; Li X
J Biol Chem; 2015 May; 290(18):11729-40. PubMed ID: 25767119
[TBL] [Abstract][Full Text] [Related]
12. Plakoglobin restores tumor suppressor activity of p53
Alaee M; Nool K; Pasdar M
Cancer Sci; 2018 Jun; 109(6):1876-1888. PubMed ID: 29660231
[TBL] [Abstract][Full Text] [Related]
13. Intracellular interferon triggers Jak/Stat signaling cascade and induces p53-dependent antiviral protection.
Shin-Ya M; Hirai H; Satoh E; Kishida T; Asada H; Aoki F; Tsukamoto M; Imanishi J; Mazda O
Biochem Biophys Res Commun; 2005 Apr; 329(3):1139-46. PubMed ID: 15752772
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J
Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor-induced STAT1 activation.
Bhattacharyya S; Zhao Y; Kay TW; Muglia LJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9554-9. PubMed ID: 21606371
[TBL] [Abstract][Full Text] [Related]
16. TSPAN12 is a critical factor for cancer-fibroblast cell contact-mediated cancer invasion.
Otomo R; Otsubo C; Matsushima-Hibiya Y; Miyazaki M; Tashiro F; Ichikawa H; Kohno T; Ochiya T; Yokota J; Nakagama H; Taya Y; Enari M
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18691-6. PubMed ID: 25512506
[TBL] [Abstract][Full Text] [Related]
17. Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells.
Taylor CA; Zheng Q; Liu Z; Thompson JE
Mol Cancer; 2013 May; 12():35. PubMed ID: 23638878
[TBL] [Abstract][Full Text] [Related]
18. The cytokine IL-6 reactivates breast stromal fibroblasts through transcription factor STAT3-dependent up-regulation of the RNA-binding protein AUF1.
Hendrayani SF; Al-Khalaf HH; Aboussekhra A
J Biol Chem; 2014 Nov; 289(45):30962-76. PubMed ID: 25231991
[TBL] [Abstract][Full Text] [Related]
19. SOCS1 regulates the IFN but not NFkappaB pathway in TLR-stimulated human monocytes and macrophages.
Prêle CM; Woodward EA; Bisley J; Keith-Magee A; Nicholson SE; Hart PH
J Immunol; 2008 Dec; 181(11):8018-26. PubMed ID: 19017994
[TBL] [Abstract][Full Text] [Related]
20. Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment.
Dong X; Li C; Deng C; Liu J; Li D; Zhou T; Yang X; Liu Y; Guo Q; Feng Y; Yu Y; Wang Z; Guo W; Zhang S; Cui H; Jiang C; Wang X; Song X; Sun X; Cao L
Oncogene; 2024 Jan; 43(2):92-105. PubMed ID: 37952080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
